Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
846
-
Total shares
-
46M
-
Shares change
-
-4.56M
-
Total reported value, excl. options
-
$7.52B
-
Value change
-
-$738M
-
Put/Call ratio
-
1.07
-
Number of buys
-
352
-
Number of sells
-
-317
-
Price
-
$163.65
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q2 2021
873 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q2 2021.
ISHARES TR - ISHARES BIOTECH (IBB) has 846 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46M shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (12.2M shares), MORGAN STANLEY (3.37M shares), UBS Group AG (2.31M shares), GOLDMAN SACHS GROUP INC (1.98M shares), CITIGROUP INC (1.82M shares), BNP PARIBAS ARBITRAGE, SA (1.8M shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (1.66M shares), JPMORGAN CHASE & CO (1.43M shares), BARCLAYS PLC (1.39M shares), and ROYAL BANK OF CANADA (1.04M shares).
This table shows the top 846 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.